Literature DB >> 27167089

Tympanoplasty in adhesive otitis media: A descriptive study.

Aisha Larem1,2, Hassan Haidar1,2, Ali Alsaadi1, Hassanin Abdulkarim1, Maryam Abdulraheem1, Sally Sheta1, Shanmugam Ganesan1,2, Amr Elhakeem1, Abdulsalam Alqahtani1,2.   

Abstract

OBJECTIVES/HYPOTHESIS: There is no consensus among clinicians regarding the best treatment strategy for adhesive otitis media (AdOM). It is common practice to only intervene in the presence of recurrent infections or significant conductive hearing loss. In an attempt to provide evidence regarding the efficacy and safety of surgical intervention, we have analyzed the long-term outcome of tympanoplasty for AdOM . STUDY
DESIGN: Prospective study.
METHODS: From January 2013 to April 2014, 57 patients with AdOM (60 ears) who fit our criteria for tympanoplasty were recruited and underwent tympanoplasty using tragal cartilage combined with transtympanic ventilation tube and cortical mastoidectomy. Otorrhea control, graft uptake, hearing level changes, and complications were evaluated within a 3-year period of follow-up.
RESULTS: Otorrhea was controlled in 94% of the ears. Tympanic membrane healing was achieved in all ears except one ear, which had myringitis. Overall there was significant improvement in hearing. Whereas the mean preoperative air-bone gap (ABG) was 30.4 ± 4.0 dB, postoperative mean ABG was 8.6 ± 6.9 dB at 1 year. Closure of ABG to within 20 dB was achieved in 46 ears (83.6%). One ear showed a drop in bone conduction level by 25 dB. No iatrogenic cholesteatoma was detected in any of the cases.
CONCLUSION: This study demonstrated that tympanoplasty has favorable outcomes in AdOM . Risks of iatrogenic sensorineural hearing loss or cholesteatoma formation are negligible. LEVEL OF EVIDENCE: 4. Laryngoscope, 126:2804-2810, 2016.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Chronic otitis media; Eustachian tube; Ossicles; cholesteatoma; erosion; hearing loss

Mesh:

Year:  2016        PMID: 27167089     DOI: 10.1002/lary.25987

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Treatment of adhesive otitis media by tympanoplasty combined with fascia grafting catheterization.

Authors:  Wenquan Li; Qiang Du; Wuqing Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-04       Impact factor: 2.503

2.  Intelligent smartphone-based multimode imaging otoscope for the mobile diagnosis of otitis media.

Authors:  Thiago C Cavalcanti; Hah Min Lew; Kyungsu Lee; Sang-Yeon Lee; Moo Kyun Park; Jae Youn Hwang
Journal:  Biomed Opt Express       Date:  2021-11-23       Impact factor: 3.732

3.  Otoendoscopy in the era of narrow-band imaging: a pictorial review.

Authors:  Federica Pollastri; Luca Giovanni Locatello; Chiara Bruno; Giandomenico Maggiore; Oreste Gallo; Rudi Pecci; Beatrice Giannoni
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-21       Impact factor: 3.236

Review 4.  Application of New Materials in Auditory Disease Treatment.

Authors:  Ming Li; Yurong Mu; Hua Cai; Han Wu; Yanyan Ding
Journal:  Front Cell Neurosci       Date:  2022-01-31       Impact factor: 5.505

5.  Cartilage tympanoplasty in the treatment of adhesive otitis media with and without Eustachian tube balloon dilatation.

Authors:  Ahmed Abdel Rahman Abdel Aziz; Ahmed Mahmoud Youssef; Mostafa Mohamed Mostafa; Mostafa Talaat; Khaled Mohamed Abdelzaher; Ahmed Adel Sadeq
Journal:  J Otol       Date:  2022-08-27

Review 6.  Success rates in restoring hearing loss in patients with chronic otitis media: A systematic review.

Authors:  Aaran Lewis; Barbara Vanaelst; Håkan Hua; Byung Yoon Choi; Rafael Jaramillo; Kelvin Kong; Jaydip Ray; Alok Thakar; Krister Järbrink; Myrthe K S Hol
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-05-12

7.  Identification of risk factors for residual cholesteatoma in children and adults: a retrospective study on 110 cases of revision surgery.

Authors:  Veronika Volgger; Göran Lindeskog; Eike Krause; Florian Schrötzlmair
Journal:  Braz J Otorhinolaryngol       Date:  2018-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.